Tech Company Financing Transactions

Corthera Funding Round

Domain Associates, Kleiner Perkins Caufield & Byers and Sears Capital Management participated in a $20 million Series C funding round for Corthera. The financing round closed on 11/2/2007.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Mailing Address
1660 S. Amphlett Blvd. 200
San Mateo, CA 94402
Email Address
Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
Corthera LinkedIn Company Profile
Social Media
Corthera Company Twitter Account
Company News
Corthera News
Corthera on Facebook
Corthera on YouTube

Management Team

Email & Social
Chief Executive Officer
Stan Abel
  Stan Abel LinkedIn Profile  Stan Abel Twitter Account  Stan Abel News  Stan Abel on Facebook
Chief Medical Officer
Sam Teichman
  Sam Teichman LinkedIn Profile  Sam Teichman Twitter Account  Sam Teichman News  Sam Teichman on Facebook
Chief Operating Officer
Rick Orr
  Rick Orr LinkedIn Profile  Rick Orr Twitter Account  Rick Orr News  Rick Orr on Facebook
Dennis Stewart
  Dennis Stewart LinkedIn Profile  Dennis Stewart Twitter Account  Dennis Stewart News  Dennis Stewart on Facebook
Vice President
Ernst Rinderknecht
  Ernst Rinderknecht LinkedIn Profile  Ernst Rinderknecht Twitter Account  Ernst Rinderknecht News  Ernst Rinderknecht on Facebook
Vice President
Elaine Unemori
  Elaine Unemori LinkedIn Profile  Elaine Unemori Twitter Account  Elaine Unemori News  Elaine Unemori on Facebook



Browse more venture capital transactions:

Prev: 11/2/2007: Vapotherm venture capital transaction
Next: 11/2/2007: HemaQuest Pharmaceuticals venture capital transaction


Share this article


Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary